By CAPosts 03 December, 2020 - 08:39pm 54 views
© Provided by Milenio Modern vaccine against coronavirus is 94.5% effective
Moderna expects to have between 100 and 125 million doses of its vaccine against covid-19 in the first quarter of 2021, the vast majority of which will go to the United States announced the US company biotecnología.
"Between 85 and 100 million of these doses will be reserved for the United States and between 15 and 25 million for the rest of the world," the laboratory noted.
also reaffirmed that 20 million doses would be available in the North American country before the end of the year.
Moderna has been preparing the supply chain with the government of Donald Trump for months to make sure it can distribute it as soon as the Drug Agency (FDA) will approve it.
For all countries outside the United States, production will take place in Switzerland, at the Lonza group factories.
Video: United Kingdom approves Pfizer and BioNTech vaccine against coronavirus (Dailymotion)
US officials have said they plan to distribute a total of 40 million doses by the end of the year in the country, including those produced by the US-German alliance Pfizer / BioNTech.
About 20 million people are expected to be vaccinated by the end of 2020 as the product is administered in two doses.
Moderna has applied for clearance from the FDA and the agency's advisory committee, which is reviewing the full clinical trial data, will meet on December 17th. Permission for distribution of the vaccine is expected shortly after.
The FDA meeting to review the Pfizer / BioNtech vaccine, which was approved yesterday in the UK, will take place on December 10.